Puborectalis Syndrome as a Phenotype of Dyssynergic Defecation in Chronic Constipation: a Comparative Study of Defecography,High-resolution Anorectal Manometry, and Pelvic Floor Ultrasound

June 28, 2026 updated by: Weidong Tong, Third Military Medical University
Patients with suspected DD who met the Rome IV criteria were divided into the DD group and other types of constipation groups. The differences between the two groups were analyzed to explore the precise diagnostic scheme for DD.

Study Overview

Detailed Description

This study was conducted solely at the Army Specialized Medical Center and was a single-center, bidirectional cohort study. Patients with suspected dyssynergic defecation who visited the constipation specialty clinic of Daping Hospital were collected. After the patients signed the informed consent form, they were asked to fill out the questionnaire (general clinical data questionnaire, Wexner constipation rating scale, ODS rating scale, and constipation patient quality of life scale (PAC-QOL)). The baseline data of the patients (such as age, gender, symptoms, constipation scale scores, intestinal satisfaction scores, etc.) and the results of anorectal manometry, defecography, and perineal ultrasound were statistically analyzed. Patients meeting the Rome IV criteria were grouped through DFG, ARM, and pelvic floor ultrasound examination. The differences in clinical main symptoms, constipation scores, defecography, perineal ultrasound, etc. between the two groups were observed, and the roles and correlations of each parameter in diagnosis were analyzed.

Study Type

Observational

Enrollment (Actual)

164

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Chongqing Municipality
      • Yuzhong, Chongqing Municipality, China, 400042
        • Army Medical Center (Daping Hospital)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

patients with suspected PRS-related DD

Description

Inclusion Criteria:

  1. Age ranges from 16 to 85 years old.
  2. Constipation patients should meet the Rome Ⅳ criteria for chronic constipation (must include two or more of the following: ① At least 25% of bowel movements are strenuous; ② At least 25% of bowel movements are lumpy or hard stools; ③ At least 25% of bowel movements are accompanied by a sense of incomplete evacuation; ④ At least 25% of bowel movements are associated with a feeling of anorectal obstruction or blockage; ⑤ At least 25% of bowel movements require manual assistance; ⑥ Fewer than 3 bowel movements per week). The healthy volunteer group has no above - mentioned constipation symptoms.
  3. Participants should be able to understand and complete relevant questionnaires.
  4. Participants should be willing to follow the research protocol and sign the informed consent form.

Exclusion Criteria:

  1. Pregnant women and lactating women
  2. Suffering from gastrointestinal and other malignant tumors
  3. Suffering from diseases such as diabetes and Parkinson's disease
  4. Currently participating in other clinical trials

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients with suspected PRS-related DD
Analysis of inter-group differences

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rectal emptying rate,(%)
Time Frame: Baseline assessment
Rectal emptying rate is defined as the reduction in rectal area from pre-evacuation to post-evacuation, expressed as a percentage of the pre-evacuation area, as assessed by defecography.
Baseline assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Obstructed Defecation Syndrome score,(ODS score)
Time Frame: Baseline assessment
the minimum value is 0,and maximum value is 31; a higher scores mean a worse outcome.
Baseline assessment
Cleveland Clinic Constipation Score,(CCCS)
Time Frame: Baseline assessment
the minimum value is 0,and maximum value is 30; a higher scores mean a worse outcome.
Baseline assessment
Patient Assessment of Constipation Quality of Life total score,(PAC-QOL score)
Time Frame: Baseline assessment
the minimum value is 0,and maximum value is 112; a higher scores mean a worse outcome.
Baseline assessment
Self-Rating Anxiety Scale score,(SAS score)
Time Frame: Baseline assessment
the minimum value is 25,and maximum value is 100; a higher scores mean a worse outcome.
Baseline assessment
Bristol Stool Form Scale score
Time Frame: Baseline assessment
the minimum value is 1,and maximum value is 7; a higher scores mean a worse outcome.
Baseline assessment
Body Mass Index
Time Frame: Baseline assessment
Baseline assessment
Disease duration,(year)
Time Frame: Baseline assessment
Baseline assessment
ARA change on DFG,(°)
Time Frame: Baseline assessment
changes in anorectal angle during defecography
Baseline assessment
Anal canal diameter on DFG,(mm)
Time Frame: Baseline assessment
anal canal diameter during straining on DFG
Baseline assessment
PRS on DFG
Time Frame: Baseline assessment
Puborectalis syndrome indicated by the defecography diagnostic report.
Baseline assessment
IRP on DFG
Time Frame: Baseline assessment
Internal rectal prolapse indicated by the defecography diagnostic report.
Baseline assessment
Rectocele on DFG
Time Frame: Baseline assessment
Rectocele indicated by the defecography diagnostic report.
Baseline assessment
Anal Resting Pressure,(mmHg)
Time Frame: Baseline assessment
Anal Resting Pressure measured by High-resolution Anorectal Manometry
Baseline assessment
Anal Squeeze Pressure,(mmHg)
Time Frame: Baseline assessment
Anal Squeeze Pressure measured by High-resolution Anorectal Manometry
Baseline assessment
Rectal propulsive pressure,(mmHg)
Time Frame: Baseline assessment
Rectal propulsive pressure measured by High-resolution Anorectal Manometry
Baseline assessment
Anal relaxation rate,(%)
Time Frame: Baseline assessment
Anal relaxation rate measured by High-resolution Anorectal Manometry during defecation
Baseline assessment
DD on HR-ARM
Time Frame: Baseline assessment
Dyssynergic defecation(DD) reported by high-resolution anorectal manometry parameters, with diagnostic criteria of rectal pressure during straining >45mmHg and anal canal relaxation rate <20%.
Baseline assessment
ARA change on TPUS,(°)
Time Frame: Baseline assessment
changes in anorectal angle during evacuation measured by Transperineal Ultrasound
Baseline assessment
Right PRM thickness change on TPUS,(mm)
Time Frame: Baseline assessment
Changes in right puborectalis muscle thickness during defecation measured by Transperineal Ultrasound
Baseline assessment
Left PRM thickness change on TPUS,(mm)
Time Frame: Baseline assessment
Changes in left puborectalis muscle thickness during defecation measured by Transperineal Ultrasound
Baseline assessment
PRS on TPUS
Time Frame: Baseline assessment
Puborectalis syndrome(PRS) indicated by the transperineal ultrasound diagnostic report
Baseline assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Weidong Tong, MD, Army Medical Center (Daping Hospital)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 21, 2023

Primary Completion (Actual)

May 31, 2026

Study Completion (Actual)

May 31, 2026

Study Registration Dates

First Submitted

June 16, 2026

First Submitted That Met QC Criteria

June 28, 2026

First Posted (Actual)

July 6, 2026

Study Record Updates

Last Update Posted (Actual)

July 6, 2026

Last Update Submitted That Met QC Criteria

June 28, 2026

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyssynergic Defecation

Clinical Trials on Analysis of inter-group differences

3
Subscribe